nabumetone
Generic: nabumetone
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
nabumetone
Generic Name
nabumetone
Labeler
asclemed usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
nabumetone 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-210
Product ID
76420-210_d9ae8825-f28b-ba4e-e053-2995a90a4487
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078420
Listing Expiration
2026-12-31
Marketing Start
2019-06-26
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420210
Hyphenated Format
76420-210
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nabumetone (source: ndc)
Generic Name
nabumetone (source: ndc)
Application Number
ANDA078420 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 7 TABLET in 1 BOTTLE (76420-210-07)
- 10 TABLET in 1 BOTTLE (76420-210-10)
- 14 TABLET in 1 BOTTLE (76420-210-14)
- 20 TABLET in 1 BOTTLE (76420-210-20)
- 30 TABLET in 1 BOTTLE (76420-210-30)
- 60 TABLET in 1 BOTTLE (76420-210-60)
Packages (6)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d9ae8825-f28b-ba4e-e053-2995a90a4487", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["LW0TIW155Z"], "rxcui": ["311892"], "spl_set_id": ["04a71deb-2c9d-436c-a574-e5991b6a5248"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "7 TABLET in 1 BOTTLE (76420-210-07)", "package_ndc": "76420-210-07", "marketing_start_date": "20220308"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (76420-210-10)", "package_ndc": "76420-210-10", "marketing_start_date": "20220308"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (76420-210-14)", "package_ndc": "76420-210-14", "marketing_start_date": "20220308"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (76420-210-20)", "package_ndc": "76420-210-20", "marketing_start_date": "20220308"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-210-30)", "package_ndc": "76420-210-30", "marketing_start_date": "20220308"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-210-60)", "package_ndc": "76420-210-60", "marketing_start_date": "20220308"}], "brand_name": "Nabumetone", "product_id": "76420-210_d9ae8825-f28b-ba4e-e053-2995a90a4487", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "76420-210", "generic_name": "Nabumetone", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nabumetone", "active_ingredients": [{"name": "NABUMETONE", "strength": "500 mg/1"}], "application_number": "ANDA078420", "marketing_category": "ANDA", "marketing_start_date": "20190626", "listing_expiration_date": "20261231"}